SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000929638-24-001775
Filing Date
2024-05-13
Accepted
2024-05-13 16:00:43
Documents
2
Group Members
BIHUA CHENCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 100428
2 JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS exhibit99-1.htm EX-99.1 11071
  Complete submission text file 0000929638-24-001775.txt   113377
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Subject) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89140 | Film No.: 24938838
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

IRS No.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G